Provided by Tiger Trade Technology Pte. Ltd.

MannKind

3.75
-0.0400-1.06%
Post-market: 3.750.00000.00%19:59 EDT
Volume:2.47M
Turnover:9.28M
Market Cap:1.21B
PE:-26.79
High:3.85
Open:3.83
Low:3.73
Close:3.79
52wk High:6.51
52wk Low:2.23
Shares:321.54M
Float Shares:309.97M
Volume Ratio:0.67
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1400
EPS(LYR):0.0200
ROE:32.74%
ROA:0.79%
PB:-17.94
PE(LYR):187.50

Loading ...

Viridian Therapeutics Q2 Net Loss Widens as Lumvoa Launch Lifts Costs

Reuters
·
Aug 06

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Scholar Rock Q2 Net Loss Narrows

Reuters
·
Aug 06

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Disc Medicine (IRON)

TIPRANKS
·
Aug 06

MannKind Q2 2026 Earnings: Revenue Rises 43% as Costs Drive a Net Loss

TradingKey
·
Aug 06

MannKind Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

MannKind reports Q2 EPS (6c), consensus 2c

TIPRANKS
·
Aug 06

Biopharma Firm MannKind Q2 Posts Net Loss on Product Launch Expenses

Reuters
·
Aug 06

MannKind Q2 Adj. EPS $(0.01) Misses $(0.00) Estimate, Sales $109.374M Beat $108.915M Estimate

Benzinga Earnings
·
Aug 06

MannKind Q2 Net Income USD -19.032 Million

Reuters
·
Aug 06

MannKind Q2 Operating Income USD -350 Thousand

THOMSON REUTERS
·
Aug 06

MannKind Q2 Basic EPS USD -0.06

THOMSON REUTERS
·
Aug 06

MannKind Corp Expected to Post Breakeven Results a Share - Earnings Preview

Reuters
·
Aug 04

MannKind Posts Transcript of Nintedanib DPI Phase 1b Results Call

Reuters
·
Aug 01

MannKind Top-Line Data From Phase 1b INFLO-1 Study 'Positive,' Wedbush Says

MT Newswires Live
·
Jul 30

MannKind is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Teva Pharmaceutical (TEVA) and MannKind (MNKD)

TIPRANKS
·
Jul 30

Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Humana (HUM)

TIPRANKS
·
Jul 30

MannKind price target raised to $14 from $11 at Wells Fargo

TIPRANKS
·
Jul 30

Earning Preview: MannKind Q2 revenue expected to rise about 39%, institutional views tilt positive

Earnings Agent
·
Jul 30